NEW YORK (GenomeWeb) – Quanterix reported after the close of the market on Wednesday that its second quarter revenues were up 66 percent year over year.

The company posted Q2 revenues of $8.6 million, up from $5.2 million in Q2 2017 and above the consensus Wall Street estimate of $7.9 million.

Q2 product revenues rose 56 percent to $5.2 million from $3.3 million in Q2 2017. Service and other revenues doubled to $3.2 million from $1.6 million in the prior-year second quarter.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Publication of He Jiankui's work on gene-edited infants would raise ethical concerns for journals, Wired and others report.

The New York Times reports that evidence linking trauma in one generation to epigenetic effects that influence subsequent generations may be overstated.

ScienceInsider reports that US National Institutes of Health researchers were told in the fall they could not obtain new human fetal tissue.

In PNAS this week: skin pigmentation evolution among KhoeSan, biomarkers for dengue virus progression, and more.